Nano Lipid Carrier System Development for Dapagliflozin: Central Composite Design Approach
Main Article Content
Abstract
Original Research: The content involves original experimental work on the development of a nano lipid
carrier system for Dapagliflozin using a central composite design approach. Methodology: It describes specific
methodologies, such as the central composite design (CCD), and includes experimental data and results. Objective
Analysis: The aim is to optimize a drug delivery system, which typically falls under the category of research
articles in scientific journals.
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.